Company Filing History:
Years Active: 2025
Title: Mi-Yeon Jung: Innovator in Fibrosis Treatment
Introduction
Mi-Yeon Jung is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. Her innovative work focuses on utilizing fatty acid synthase inhibitors to address this challenging condition.
Latest Patents
Mi-Yeon Jung holds a patent for "Using fatty acid synthase inhibitors to treat fibrosis." This patent relates to materials and methods for treating fibrosis, including pulmonary fibrosis. The document outlines methods for using one or more fatty acid synthase (FASN) inhibitors to treat mammals suffering from fibrosis and complications associated with it, such as hypoxia caused by pulmonary fibrosis. She has 1 patent to her name.
Career Highlights
Mi-Yeon Jung is affiliated with the Mayo Foundation for Medical Education and Research, where she conducts her research. Her work is instrumental in advancing the understanding and treatment of fibrosis, contributing to improved patient outcomes.
Collaborations
Some of her notable coworkers include Edward B Leof and Ruth Lupu, who collaborate with her on various research projects.
Conclusion
Mi-Yeon Jung's innovative approach to treating fibrosis through fatty acid synthase inhibitors showcases her dedication to medical research and her impact on the field. Her contributions are paving the way for new treatment options for patients suffering from this condition.